MK-677 (Ibutamoren): Benefits, Dosage, Side Effects, and How to Get It

MK-677, also called ibutamoren, is an oral compound studied for body composition, recovery, sleep, and appetite. It is not a peptide. It acts on the same growth hormone pathway as several peptide therapies.

What is MK-677?

MK-677 (ibutamoren) is a synthetic small molecule that mimics the action of ghrelin, the hormone that stimulates hunger and growth-hormone release. It is a non-peptide compound — unlike the GHRH analogs and secretagogue peptides on the rest of this site, it is not built from amino acids.

It produces a peptide-like effect on the growth-hormone axis through a different chemical class, which is why it sits alongside peptides in searches and stacks even though it is structurally distinct.

Is MK-677 a peptide?

No. MK-677 is a non-peptide growth-hormone secretagogue. It is a small organic molecule, not a chain of amino acids. People group it with peptides like ipamorelin and sermorelin because it acts on the same growth-hormone pathway and is used for the same goals, but the chemistry is different.

This distinction also matters for its regulatory status: MK-677 is not on the 2026 peptide reclassification list, because that list covers peptides.

Benefits and uses

What MK-677 is used for, by raising GH and IGF-1:

• Body composition. Sustained elevation of GH and IGF-1 is used to support lean mass and fat metabolism.
• Appetite increase. Because it acts on the ghrelin receptor, MK-677 reliably increases appetite — useful for those trying to gain, a drawback for those cutting.
• Sleep. Users report deeper sleep, consistent with GH's role in slow-wave sleep.
• Recovery. Elevated GH and IGF-1 support soft-tissue repair.

The oral route is the practical draw — it produces GH-axis effects without subcutaneous injection.

How it works

MK-677 binds the ghrelin receptor (the growth-hormone secretagogue receptor) in the pituitary and hypothalamus, mimicking ghrelin's signal to release growth hormone. The released GH raises IGF-1, and the ghrelin-receptor activity also drives the appetite increase.

Because it's orally bioavailable and long-acting, a single daily dose maintains elevated GH and IGF-1 around the clock — a different pattern from the short pulses produced by injectable secretagogues.

Dosage and administration

MK-677 is taken orally, typically once daily, which is its main point of difference from injectable GH peptides. Commonly cited ranges run in the milligram-per-day region, often taken at night to align with sleep.

These are not official dosing guidelines — MK-677 is a research chemical, not an FDA-approved product — and any use should be supervised by a provider.

If you are stacking it with injectable peptides, the peptide dosage calculator covers the injectable side of the protocol.

Side effects and safety

MK-677's side effects follow from sustained GH elevation and ghrelin-receptor activity, and they warrant active monitoring:

• Water retention. Common, from elevated GH.
• Increased appetite. Expected, and can be unwanted on a cut.
• Raised blood sugar. GH reduces insulin sensitivity, so fasting glucose and HbA1c can rise — the most important safety item to track.
• Lethargy or fatigue in some users.

MK-677 is a research chemical and not FDA-approved for human use. Because of the blood-sugar effect in particular, anyone using it should monitor glucose and metabolic markers and work with a provider.

Legal status and how to get MK-677

MK-677 is a research chemical, not an FDA-approved medication, and it is not on the April 2026 list of 12 peptides removed from the Section 503A Category 2 restriction — that list covers peptides, and MK-677 is a non-peptide compound.

The July 2026 advisory committee did not consider it. Products sold online for research use are not manufactured or quality-controlled for human use. Buying them carries quality and legal risk.

Blood work to track MK-677

MK-677 raises GH and IGF-1 and can raise blood sugar, so tracking covers both effectiveness and the specific safety risk:

• IGF-1 — the direct readout of the GH effect. It should rise if MK-677 is working.
• Comprehensive metabolic profile — fasting glucose, liver enzymes, and kidney function. The glucose number matters specifically here, because MK-677 can reduce insulin sensitivity.

Test before you start and again during use, watching glucose in particular.

Related peptides

MK-677 is most often stacked with or compared against the injectable growth-hormone peptides that act on the same GH axis: Ipamorelin and CJC-1295, the secretagogue and GHRH analog frequently run together, and Sermorelin, the established prescription GHRH analog.

For a broader GH-axis protocol, compare the options in peptides for muscle and performance.